Amir Nour mohammadi

Dr. Amir Nour mohammadi

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2025 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
MKMarcin Kubiak
Marcin Kubiak
JDJacek Doniec
Jacek Doniec
SGS. Vincent Grasso
S. Vincent Grasso
AGAndrew Gumbs
Andrew Gumbs
AMAmir Nour mohammadi
Amir Nour mohammadi
KRKarol Rawicz-Pruszyński
Karol Rawicz-Pruszyński
Since its introduction in 2010, a dynamic growth of robotic-assisted surgery (RAS) has been observed in Poland. The number of healthcare institutions implementing RAS has tripled in the last 36 months, with 80 surgical robots currently utilized on a national scale. While urological procedures dominate RAS utilization (73%), adoption in gynecology (12.2%) and gastrointestinal surgery (8.5%) is rising, driven by recent National Health Fund reimbursement policies. However, significant fragmentation and alarmingly low numbers of individual RAS procedures were identified: 47.7% of surgeons perform less than 40 cases annually. Parallel to expanding the robotic surgery reimbursement program, several standardized actions are warranted to further facilitate and optimize modern surgical practices in Poland. Regional disparities in access and underutilization of robotic systems, followed by a lack of a centralized and standardized registry to evaluate surgical and oncological outcomes, represent the main challenges to integrating robotic surgery nationally. Addressing these, followed by implementing structured training and uniform evaluation frameworks for clinical and oncological outcomes, are critical to maximizing the potential of surgical robotic systems in Poland.

23 March 2026 in Cancers
Verified
Journal Article
Open access
PDF file
Andrew A. GumbsAndrew A. Gumbs
Andrew A. Gumbs
Roland S. CronerRoland S. Croner
Roland S. Croner
DFDavid Fuks
David Fuks
HTHadrien Tranchart
Hadrien Tranchart
ZHZacharias Heger
Zacharias Heger
IDIbrahim Dagher
Ibrahim Dagher
Background: The role of minimally invasive surgery (MIS) for hepatocellular carcinoma (HCC) remains controversial because of concerns regarding oncologic adequacy, particularly margin status. While robotic-assisted hepatectomy has gained adoption, its true perioperative advantages over conventional laparoscopy and open surgery remain unclear. SIMMILR-5 was designed to evaluate the short-term outcomes of open, laparoscopic, and tele-robotic laparoscopic hepatectomy for HCC using rigorous adjustment for confounding. Methods: A retrospective international multicenter study was conducted including patients undergoing liver resection for HCC between June 2004 and November 2024 at five high-volume hepatobiliary centers. Surgical approaches included open (O), conventional laparoscopy (L), and tele-robotic laparoscopy (TRL). Propensity score matching was performed using demographic, clinical, and tumor-related variables. The primary endpoint was short-term mortality (30 and 90 days). Secondary outcomes included estimated blood loss (EBL), operative time, length of stay (LOS), R0 resection status, and major complications. Results: A total of 904 patients were identified (302 O, 568 L, 34 TRL). After matching, conventional laparoscopy was associated with significantly lower EBL, shorter operative time, and shorter LOS compared with open surgery (all p < 0.00001). Compared with open surgery, TRL was associated with lower EBL but no improvement in operative time or LOS. Compared with laparoscopy, TRL was associated with longer operative time and longer LOS. Short-term oncologic surrogates were comparable across approaches. Conclusions: Minimally invasive hepatectomy offers perioperative advantages over open surgery for selected patients with HCC, driven primarily by conventional laparoscopy. Tele-robotic hepatectomy is feasible and safe in experienced centers but does not demonstrate superiority over advanced laparoscopic techniques.

5 October 2026 in Rheumatology International
Verified
Journal Article
Open access
PDF file
AGAleksandra Gałan
Aleksandra Gałan
FKFilip Koszałka
Filip Koszałka
IZIzabela Zakrocka
Izabela Zakrocka
AMAmir Nour mohammadi
Amir Nour mohammadi
JKJakub Jan Kleinrok
Jakub Jan Kleinrok
WZWojciech Załuska
Wojciech Załuska
Antineutrophil cytoplasmic antibodies (ANCA)-negative pauci-immune necrotizing glomerulonephritis (PING) is a rare entity, representing a distinct subset of small-vessel vasculitis. The absence of ANCA does not exclude the diagnosis, and clinical suspicion should remain high in the presence of compatible systemic and renal findings. We present the case of a 22-year-old woman with recurrent, non-specific cutaneous manifestations since early childhood, who was hospitalized for an exacerbation of skin lesions. Laboratory results revealed nephrotic-range proteinuria of 17 g/d [N < 150 mg/d] and a reduced estimated glomerular filtration rate (eGFR) of 47 mL/min/1.73 m² [N > 90 mL/min/1.73 m²]. Renal biopsy results demonstrated cellular crescents, focal segmental tubular necrosis, intense mononuclear inflammatory infiltrates, and segmental proliferation of Bowman’s capsule epithelial cells. Direct immunofluorescence yielded negative results for IgG, IgA, IgM, C3, or C1q deposits. Electron microscopy confirmed segmental podocyte foot process effacement and microvillous transformation. Serologic testing was comprehensively negative, specifically confirming the absence of PR3-ANCA, MPO-ANCA, anti-glomerular basement membrane (GBM) antibodies, and serum cryoglobulins. Based on the clinical, histologic, and immunopathologic findings, a definitive diagnosis of isolated ANCA-negative PING was established, although atypical features prompted the consideration of secondary podocytopathy. Methylprednisolone therapy was initiated, but progressive renal deterioration following a substantial loss to follow-up period necessitated renal replacement therapy. This report underscores the diagnostic challenge of ANCA-negative PING, given its absent serologic markers and overlapping features with other glomerular diseases, highlighting the crucial role of renal biopsy in reaching a timely diagnosis.

28 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FKFilip Koszałka
Filip Koszałka
AGAleksandra Gałan
Aleksandra Gałan
AMAmir Nour mohammadi
Amir Nour mohammadi
JGJagoda Góra
Jagoda Góra
IZIzabela Zakrocka
Izabela Zakrocka
WZWojciech Załuska
Wojciech Załuska
Background: Genetic testing is an increasingly important component in the diagnostic evaluation of kidney diseases. Pathogenic variants in the HNF1B gene cause a disorder classically known as renal cysts and diabetes (RCAD) syndrome, typically characterised by bilateral renal cysts, diabetes mellitus, and a broad spectrum of other extrarenal abnormalities. However, non-cystic presentations often lead to diagnostic delays. Case Report: We report the case of a 28-year-old woman evaluated for chronic kidney disease of unknown aetiology who presented with atypical radiological findings. Imaging revealed bilateral renal hypoplasia completely devoid of cystic transformation. The patient exhibited no proteinuria, electrolyte or acid–base disturbances, diabetes mellitus, or pancreatic abnormalities. Next-generation sequencing identified pathogenic HNF1B missense variant (p.Met160Val), confirming the diagnosis of genetic kidney disease. The patient’s clinical course remained stable throughout the follow-up period. Conclusions: This case illustrates the marked phenotypic heterogeneity of HNF1B-associated disease and supports incorporating genetic testing in patients with unexplained structural kidney abnormalities, even in the absence of classical cystic renal disease or typical extrarenal manifestations, to ensure accurate diagnosis and treatment, and to facilitate appropriate family counselling.

4 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Andrew A. GumbsAndrew A. Gumbs
Andrew A. Gumbs
Roland S. CronerRoland S. Croner
Roland S. Croner
DFDavid Fuks
David Fuks
IDIbrahim Dagher
Ibrahim Dagher
HTHadrien Tranchart
Hadrien Tranchart
Mohammed Abu HilalMohammed Abu Hilal
Mohammed Abu Hilal
Introduction: This international multicenter study compared five surgical approaches for liver resection in colorectal metastases: open (O), standard laparoscopy (L), laparoscopy with 3D imaging (3D), laparoscopy with single robotic-arm assistance (1RA), and with complete robotic systems utilizing 4 robotic arms(4RA). A subcohort analysis was done for enhanced L, this cohort was termed collaborative assisted robotics (cobotic surgery) and consisted of L with the addition of 3D imaging or a single robotic arm to hold the laparoscope. This study aimed to evaluate whether 4RA offers any significant advantages over laparoscopy with and without cobotic enhancements. Methods: We analyzed 1,257 patients across five centers using propensity score matching. Surgical approaches were compared for blood loss, operative time, hospital stay, resection margins (R0 status), and major complications (Clavien-Dindo grade ≥3). Statistical analysis used Student's t-test and Mann-Whitney U-test for continuous variables, with p<0.05 considered significant. Results: Minimally invasive techniques without 3-D imaging, a solitary robotic arm to hold the laparoscope or utilization of handheld robotic GIA staplers showed superior outcomes to open surgery. Laparoscopic approaches demonstrated significantly reduced blood loss (L: 553 mL vs O: 695 mL, p<0.001) and shorter hospital stays when compared to open surgery (L: 8 days vs O: 14 days, p<0.001). The 4RA cohort had similar benefits when compared to O resection (blood loss: 382 mL vs 542 mL, p<0.001; LOS: 8 vs 24 days, p<0.001), but longer operative times (280 vs 305 minutes (min), p<0.001). The 1RA and 3D approaches showed comparable outcomes to 4RA in most measures. Conclusions: While robotic assistance offers technical advantages, complete robotic systems (4RA) did not demonstrate clear superiority over laparoscopy with or without cobotics. Cost-effective modular enhancements to standard laparoscopy may provide future benefits while allowing resource allocation toward AI-driven surgical innovations. Future studies should employ prospective designs with standardized protocols to validate these findings and assess long-term oncologic outcomes.

29 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
WGWojciech Górski
Wojciech Górski
MKMarcin Kubiak
Marcin Kubiak
AMAmir Nour mohammadi
Amir Nour mohammadi
MPMaksymilian Podleśny
Maksymilian Podleśny
GBGian Luca Baiocchi
Gian Luca Baiocchi
KRKarol Rawicz-Pruszyński
Karol Rawicz-Pruszyński
Introduction: By leveraging dedicated datasets and predictive modeling, machine-learning (ML) algorithms can estimate the probability of both short- and long-term outcomes after surgery. The aim of this study was to evaluate the ability of ML-based models to predict postoperative complications in patients with gastric cancer (GC) undergoing multimodal therapy. In particular, we aimed to develop a free, publicly accessible online calculator based on preoperative variables. Materials and Methods: Patients with histologically confirmed locally advanced (cT2-4N0-3M0) GC who underwent multimodal treatment with curative intent between 2013 and 2023 were included in the study. ML models evaluation pipeline was used with Stratified 5-Fold Cross-Validation. Results: A total of 368 patients were included in the final analytic cohort. Among five algorithm classes under 5-fold cross-validation, Compute Area Under the Receiver Operating Characteristic Curve (ROC AUC) was 0.9719, 0.9652, 0.9796, 0.8339 and 0.7581 for XGBoost, Catboost, Random Forest, SVM and Logistic Regression, respectively. Macro F1 was 0.8714, 0.5094, 0.8820, 0.8714 and 0.4579 for XGBoost, SVM, Random Forest, CatBoost and Logistic Regression, respectively. Overall Accuracy was 0.8897, 0.5980, 0.8885, 0.8750 and 0.5466 for XGBoost, SVM, Random Forest, CatBoost and Logistic Regression models, respectively. Conclusions: In this Central and Eastern European cohort of patients with locally advanced GC, ML models using non-linear decision rules-particularly Random Forest and XGBoost- substantially outperformed conventional linear approaches in predicting the severity of postoperative complications. Prospective external validation is needed to clarify the model’s clinical utility and its potential role in perioperative decision support.